'Lymphocytic leukemia' diaporamas de présentation

Toxicological Emergencies in the Oncology Patient: Antidotal Therapies

Toxicological Emergencies in the Oncology Patient: Antidotal Therapies. 2008 ACMT Pre-Meeting Symposium Rama B. Rao, MD NYCPCC NYPH-Weill-Cornell Medical Center. Methotrexate and Carboxypeptidase G 2 GLUCARPIDASE. FOLATE METABOLISM. Dihydrofolate reductase (DHFR). Tetrahydrofolate (THF).

1.19k views • 96 slides

Origins and Evolution of Novel Genes

922 views • 72 slides

LEUKEMIAS

LEUKEMIAS. Dr.Nazzal Bsoul Hematologist Al Bashir Hospital. Terminology. Leukos: White Aimia: Blood Leuk e mia--------Leuk ae mia ? H e matology-----H ae matology ? Leukemoid reaction:. Definition.

972 views • 46 slides

Pharmacology Part 2

Pharmacology Part 2. Pharmacology consists of pharmacodynamics and pharmacokinetics Pharmacodynamics describes how a drug acts in the body Pharmacokinetics describes how the body acts on the drug. Drugs and mechanisms of action.

555 views • 30 slides

Unusual Case of Myasthenia Gravis and High White Blood Cell Count

Eddie L. Patton, M.D., M.S. Yadollah Harati, M.D., F.A.C.P. Unusual Case of Myasthenia Gravis and High White Blood Cell Count. Clinical Presentation. This is the case of a 52 year old man with a 5 week history of left eyelid droop

591 views • 27 slides

Unusual Case of Myasthenia Gravis and High White Blood Cell Count

Eddie L. Patton, M.D., M.S. Yadollah Harati, M.D., F.A.C.P. Unusual Case of Myasthenia Gravis and High White Blood Cell Count. Clinical Presentation. This is the case of a 52 year old man with a 5 week history of left eyelid droop

406 views • 27 slides

1 Byrd JC et al. Proc ASH 2012; Abstract 189.

261 views • 19 slides

Blood-Based Detection of Carcinogenic Environmental Exposures Stephen G. Grant

Center for Environmental Oncology University of Pittsburgh Cancer Institute. Blood-Based Detection of Carcinogenic Environmental Exposures Stephen G. Grant. Tobacco comprises: 1. Cigarette constituents Organic matter Nicotinic alkyloids Additives 2. Pyrolysis products Carbon dioxide

275 views • 19 slides

Geisler C et al. Proc ASH 2011;Abstract 290.

143 views • 8 slides

Anti-lymphocyte Tumor Mechanism of CD19-CART Cells

Lymphoid malignancies include lymphocytic leukemia and lymphoma, which are tumors that occur on lymphocytes such as B cells, T cells, and NK cells. At present, there are many difficulties in its treatment, which are related to the recurrence and refractory of the diseases in the clinic. In the past 10 years, great progress has been made in the clinical treatment of lymphatic system tumors. Anti-CD20 monoclonal antibodies have been widely used in CD20-positive B-cell non-Hodgkin's lymphomas, and have achieved good results, becoming the first-line clinical application. However, since the cell surface of lymphoma and acute-chronic lymphocytic leukemia often has only CD19 antigen, an anti-CD20 antibody such as rituximab has no obvious therapeutic effect on it, therefore there is an urgent need for a new treatment method to improve the cure rate of lymphoma and acute and chronic lymphoma.

160 views • 8 slides

CAR-T cell Therapy Market Expected To Exhibit Double Digit Growth During The Forecast Period

The global CAR-T cell therapy market was valued at US$ 72.0 Mn in 2017 expanding at a CAGR of 51.1% from 2018 to 2026.

45 views • 4 slides